October 20, 2025

Positrigo, a Swiss-based company developing nuclear medical devices to advance functional brain imaging, is pleased to announce the appointment of Matthieu Cousteau as the company’s new Group Chief Financial Officer (CFO). With a wealth of experience in finance leadership and a proven track record of scaling global businesses, Matthieu will play a pivotal role in driving the company’s next phase of growth, strategic investments, and global expansion.

As CFO, Matthieu will oversee Positrigo’s global finance operations, including financial planning and analysis, capital strategy, and risk management. His deep expertise in financial strategy, combined with his strong background in navigating complex business environments, will help guide Positrigo through its continued evolution as a market leader.

“We are thrilled to welcome Matthieu to the Positrigo team,” says Jannis Fischer, Co-Founder and CEO of Positrigo. “His vast experience and sharp strategic insight will be invaluable as we expand our presence worldwide and continue to innovate in medical imaging. Matthieu’s leadership will be instrumental in positioning us for long-term growth and value creation.”

Matthieu brings nearly two decades years of experience in corporate finance and strategic management, having held transformational & senior positions across various sectors such as cosmetics, governmental services, packaging and auto industry . Throughout his career, Matthieu has demonstrated a keen ability to optimize group structures including operations, support growth strategies, build & raise capital for new ventures, and lead successful financial transformations at global companies.

“I am excited to join Positrigo at such a transformative time,” states Matthieu Cousteau. “The company has tremendous potential within a societal topic, and I look forward to contributing to its growth trajectory. Together with the talented team at Positrigo, I am confident that we will continue to drive innovation, maximize value for our stakeholders, and create new opportunities in the global market.”

Positrigo is a leader in dedicated brain Positron Emission Tomography (PET) imaging technology and Matthieu’s appointment reflects the company’s commitment to investing in top-tier talent to support its ongoing expansion and operational excellence.